Benjafield AV, Ayas NT, Eastwood PR et al (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7(8):687–698. https://doi.org/10.1016/S2213-2600(19)30198-5

Article  PubMed  PubMed Central  Google Scholar 

Tietjens JR, Claman D, Kezirian EJ et al (2019) Obstructive sleep apnea in cardiovascular disease: A review of the literature and proposed multidisciplinary clinical management strategy. J Am Heart Assoc 8(1):e010440. https://doi.org/10.1161/JAHA.118.010440

Article  PubMed  Google Scholar 

Gottlieb DJ, Punjabi NM (2020) Diagnosis and management of obstructive sleep apnea: A review. JAMA 323(14):1389–1400. https://doi.org/10.1001/jama.2020.3514

Article  PubMed  Google Scholar 

Fu Y, Xia Y, Yi H, Xu H, Guan J, Yin S (2017) Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment. Sleep Breath 21(1):181–189. https://doi.org/10.1007/s11325-016-1393-1

Article  PubMed  Google Scholar 

Dodds S, Williams LJ, Roguski A et al. (2020) Mortality and morbidity in obstructive sleep apnoea-hypopnoea syndrome: results from a 30-year prospective cohort study. ERJ Open Res 6(3). https://doi.org/10.1183/23120541.00057-2020

Owens RL, Eckert DJ, Yeh SY, Malhotra A (2008) Upper airway function in the pathogenesis of obstructive sleep apnea: a review of the current literature. Curr Opin Pulm Med 14(6):519–524. https://doi.org/10.1097/MCP.0b013e3283130f66

Article  PubMed  PubMed Central  Google Scholar 

Keenan BT, Kim J, Singh B, et al. (2018) Recognizable clinical subtypes of obstructive sleep apnea across international sleep centers: a cluster analysis. Sleep 41(3). https://doi.org/10.1093/sleep/zsx214

Schmickl CN, Owens RL, Edwards BA, Malhotra A (2018) OSA endotypes: what are they and what are their potential clinical implications? Curr Sleep Med Rep 4(3):231–242. https://doi.org/10.1007/s40675-018-0121-8

Article  Google Scholar 

Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A (2013) Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med 188(8):996–1004. https://doi.org/10.1164/rccm.201303-0448OC

Epstein LJ, Kristo D, Strollo PJ et al (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5(3):263–276. https://doi.org/10.5664/jcsm.27497

Article  PubMed  Google Scholar 

Engleman HM, Wild MR (2003) Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev 7(1):81–99

Article  PubMed  Google Scholar 

Kribbs NB, Pack AI, Kline LR et al (1993) Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147(4):887–895. https://doi.org/10.1164/ajrccm/147.4.887

Article  PubMed  Google Scholar 

Li H-Y, Lee L-A, Tsai M-S et al (2020) How to manage continuous positive airway pressure (CPAP) failure -hybrid surgery and integrated treatment. Auris Nasus Larynx 47(3):335–342. https://doi.org/10.1016/j.anl.2020.03.007

Article  PubMed  Google Scholar 

Jordan AS, McSharry DG, Malhotra A (2014) Adult obstructive sleep apnoea. Lancet 383(9918):736–747. https://doi.org/10.1016/S0140-6736(13)60734-5

Article  PubMed  Google Scholar 

Fenik VB, Davies RO, Kubin L (2005) REM sleep-like atonia of hypoglossal (XII) motoneurons is caused by loss of noradrenergic and serotonergic inputs. Am J Respir Crit Care Med 172(10):1322–1330. https://doi.org/10.1164/rccm.200412-1750OC

Article  PubMed  Google Scholar 

Chan E, Steenland HW, Liu H, Horner RL (2006) Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states. Am J Respir Crit Care Med 174(11):1264–1273. https://doi.org/10.1164/rccm.200605-597OC

Article  PubMed  Google Scholar 

Grace KP, Hughes SW, Horner RL (2013) Identification of the mechanism mediating genioglossus muscle suppression in REM sleep. Am J Respir Crit Care Med 187(3):311–319. https://doi.org/10.1164/rccm.201209-1654OC

Article  PubMed  Google Scholar 

Grace KP, Hughes SW, Horner RL (2014) Identification of a pharmacological target for genioglossus reactivation throughout sleep. Sleep 37(1):41–50. https://doi.org/10.5665/sleep.3304

Article  PubMed  PubMed Central  Google Scholar 

Aishah A, Lim R, Sands SA et al (2021) Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity. J Appl Physiol 130(5):1373–1382. https://doi.org/10.1152/japplphysiol.01074.2020

Article  PubMed  PubMed Central  Google Scholar 

Aishah A, Loffler KA, Toson B et al (2023) One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized. Placebo-controlled Trial Ann Am Thorac Soc 20(4):584–595. https://doi.org/10.1513/AnnalsATS.202206-492OC

Article  PubMed  Google Scholar 

Altree TJ, Aishah A, Loffler KA, Grunstein RR, Eckert DJ (2023) The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial. J Clin Sleep Med 19(1):85–96. https://doi.org/10.5664/jcsm.10256

Article  PubMed  PubMed Central  Google Scholar 

Perger E, Taranto Montemurro L, Rosa D et al (2022) Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled. Double-Blind Crossover Trial Chest 161(1):237–247. https://doi.org/10.1016/j.chest.2021.08.080

Article  PubMed  Google Scholar 

Berger M, Solelhac G, Marchi NA et al. (2023) Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial. Sleep 46(7). https://doi.org/10.1093/sleep/zsad051

Rosenberg R, Abaluck B, Thein S (2022) Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA. J Clin Sleep Med 18(12):2837–2844. https://doi.org/10.5664/jcsm.10250

Article  PubMed  PubMed Central  Google Scholar 

Kinouchi T, Terada J, Sakao S et al (2023) Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial. Respirology 28(3):273–280. https://doi.org/10.1111/resp.14383

Article  PubMed  Google Scholar 

Taranto-Montemurro L, Messineo L, Azarbarzin A et al (2020) Effects of the combination of atomoxetine and oxybutynin on OSA endotypic traits. Chest 157(6):1626–1636. https://doi.org/10.1016/j.chest.2020.01.012

Article  PubMed  PubMed Central  Google Scholar 

Schweitzer PK, Maynard JP, Wylie PE, Emsellem HA, Sands SA (2023) Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility. Sleep Breath 27(2):495–503. https://doi.org/10.1007/s11325-022-02634-x

Article  PubMed  Google Scholar 

Messineo L, Taranto-Montemurro L, Calianese N et al (2022) Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility. Respirology 27(11):975–982. https://doi.org/10.1111/resp.14326

Article  PubMed  PubMed Central  Google Scholar 

Lim R, Messineo L, Grunstein RR, Carberry JC, Eckert DJ (2021) The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial. J Physiol (Lond) 599(17):4183–4195. https://doi.org/10.1113/JP281912

Article  PubMed  Google Scholar 

Taranto-Montemurro L, Messineo L, Sands SA et al. (2019) The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial. Am J Respir Crit Care Med 199(10):1267–1276. https://doi.org/10.1164/rccm.201808-1493OC

Zha S, Yang H, Yue F, Zhang Q, Hu K (2022) Combined noradrenergic plus antimuscarinic agents for obstructive sleep apnea - A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev 64:101649. https://doi.org/10.1016/j.smrv.2022.101649

Article  PubMed  Google Scholar 

Lee Y-C, Lu C-T, Chuang L-P et al (2023) Pharmacotherapy for obstructive sleep apnea - A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev 70:101809. https://doi.org/10.1016/j.smrv.2023.101809

Article  PubMed  Google Scholar 

Taranto-Montemurro L, Pho H, White DP (2023) Development of a combination of noradrenergic and antimuscarinic drugs for the treatment of obstructive sleep apnea: Challenges and progress. Front Sleep 2. https://doi.org/10.3389/frsle.2023.1148282

Schweitzer PK, Taranto-Montemurro L, Ojile JM et al (2023) The combination of aroxybutynin and atomoxetine in the treatment of obstructive sleep apnea (MARIPOSA): A randomized controlled trial. Am J Respir Crit Care Med 208(12):1316–1327. https://doi.org/10.1164/rccm.202306-1036OC

Article  PubMed  PubMed Central  Google Scholar 

Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151(4):W65-94.